Articles by Hellen Berger - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Hellen Berger

Global Instability Affects the Pharma Market in Brazil

How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?
Apr 1, 2014

How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?

Innovation and Market Growth in Brazil

Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.
Jan 1, 2014

Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.

Report from Brazil

New regulation offers patients in Brazil greater access to experimental drugs.
Nov 1, 2013

New regulation offers patients in Brazil greater access to experimental drugs.

Report from Brazil

Pharma eyes biologics production in Brazil as the government begins to recognize the potential of these drugs.
Sep 1, 2013

Pharma eyes biologics production in Brazil as the government begins to recognize the potential of these drugs.

Report from Brazil

Brazil offers opportunities and challenges for global pharmaceutical companies.
Jul 1, 2013

Brazil offers opportunities and challenges for global pharmaceutical companies.

Report from Brazil

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.
May 1, 2013

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Report from Brazil

Brazil's major vaccine producer innovates with stem-cell research.
Mar 1, 2013

Brazil's major vaccine producer innovates with stem-cell research.

Report from Brazil

Brazil to locally produce HIV/AIDS antiretroviral drug atazanavir.
Jan 1, 2013

Brazil to locally produce HIV/AIDS antiretroviral drug atazanavir.

Report from Brazil

Brazil's regulatory health authority, Anvisa, plans to establish quality requirements for locally produced pharmaceutical excipients, Anvisa told BioPharm International.
Sep 1, 2012

Brazil's regulatory health authority, Anvisa, plans to establish quality requirements for locally produced pharmaceutical excipients, Anvisa told BioPharm International.

ADVERTISEMENT

ADVERTISEMENT

Click here